Human papillomavirus vaccination and regular screening: actions against cervical cancer
The turquoise and white ribbon reminds of the importance of timely diagnosis and the availability of modern prevention for every woman.
Cervical Cancer Action Day November 17: Prevention and Screening. Illustrative photoEvery year on November 17, the international medical community marks Cervical Cancer Elimination Day of Action. This date was initiated by the World Health Organization (WHO) in 2020, when 194 countries of the world adopted a global strategy for the complete elimination of this cancer as a public health problem for the first time in history.
The turquoise and white ribbon is a symbol of solidarity and awareness . During this day, medical institutions, architectural monuments and public buildings in many countries are illuminated in turquoise to draw public attention to a disease that modern medicine can effectively prevent.
WHO Global Formula “90 – 70 – 90” and Key Risk Factors
According to medical statistics, cervical cancer ranks fourth among the most common cancers in women in the world. The main cause of the development of the pathology (in more than 95 percent of cases) is long-term infection with oncogenic strains of the human papillomavirus (HPV) , primarily types 16 and 18.
To stop the spread of the disease, WHO has identified three key targets by 2030, known as the “90-70-90” strategy:
- 90 percent of girls should be fully vaccinated against human papillomavirus by the age of 15;
- 70 percent of women should undergo high-precision screening before the age of 35 and again before the age of 45;
- 90 percent of patients diagnosed with precancerous conditions or invasive cervical cancer should receive timely and high-quality treatment.
The role of regular screening in maintaining women's health
The insidiousness of cervical cancer is that in the early stages and the stage of precancerous changes (dysplasia), the disease is usually asymptomatic. That is why regular preventive examinations by a gynecologist play a crucial role, even in the absence of complaints.
Modern diagnostics relies on two proven tools: cytological examination of a smear ( PAP test or liquid cytology), which allows to detect the slightest structural changes in cells, and HPV testing for the presence of a high oncogenic risk virus. Timely detection of precancerous changes allows for gentle intervention and completely prevents the development of a malignant process.
Read more news on GreenPost.

